In the BioHarmony Drug Report Database

"Preview" Icon

Velpatasvir

Epclusa (velpatasvir) is a small molecule pharmaceutical. Velpatasvir was first approved as Epclusa on 2016-06-28. It is used to treat chronic hepatitis c and hepatitis c in the USA. It has been approved in Europe to treat chronic hepatitis c. Epclusa’s patents are valid until 2034-01-30 (FDA).

 

Trade Name

 

Epclusa
 

Common Name

 

velpatasvir
 

ChEMBL ID

 

CHEMBL3545062
 

Indication

 

chronic hepatitis c, hepatitis c
 

Drug Class

 

Antivirals: NS5A inhibitors

Image (chem structure or protein)

Velpatasvir structure rendering